Hung Tseng to Herpes Zoster
This is a "connection" page, showing publications Hung Tseng has written about Herpes Zoster.
Connection Strength
10.687
-
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged =50 years in the United States. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2327145.
Score: 0.858
-
Risk of herpes zoster following mRNA COVID-19 vaccine administration. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):643-649.
Score: 0.789
-
Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older. Vaccine. 2021 02 05; 39(6):926-932.
Score: 0.688
-
Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. J Manag Care Spec Pharm. 2020 Dec; 26(12):1567-1575.
Score: 0.677
-
The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults =50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence. J Infect Dis. 2020 08 04; 222(5):798-806.
Score: 0.668
-
Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live. Vaccine. 2019 06 06; 37(26):3478-3484.
Score: 0.613
-
Family history of zoster and risk of developing herpes zoster. Int J Infect Dis. 2018 Jan; 66:99-106.
Score: 0.553
-
Receipt of thyroid hormone deficiency treatment and risk of herpes zoster. Int J Infect Dis. 2017 Jun; 59:90-95.
Score: 0.532
-
Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged =60 Years. J Infect Dis. 2016 06 15; 213(12):1872-5.
Score: 0.489
-
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Clin Infect Dis. 2016 Feb 15; 62(4):462-7.
Score: 0.484
-
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. J Infect Dis. 2015 Oct 15; 212(8):1222-31.
Score: 0.466
-
Vaccination against zoster remains effective in older adults who later undergo chemotherapy. Clin Infect Dis. 2014 Oct; 59(7):913-9.
Score: 0.441
-
Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis. 2014 Apr; 58(8):1125-8.
Score: 0.425
-
Trends and disparity in zoster vaccine uptake in a managed care population. Vaccine. 2013 Sep 23; 31(41):4564-8.
Score: 0.411
-
Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population. J Infect Dis. 2012 Jul 15; 206(2):190-6.
Score: 0.379
-
Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. J Intern Med. 2012 May; 271(5):510-20.
Score: 0.365
-
Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Vaccine. 2011 May 09; 29(20):3628-32.
Score: 0.349
-
Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011 Jan 12; 305(2):160-6.
Score: 0.344
-
Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. Pediatr Infect Dis J. 2010 Mar; 29(3):205-8.
Score: 0.324
-
Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008. Pediatr Infect Dis J. 2009 Dec; 28(12):1069-72.
Score: 0.319
-
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. Am J Epidemiol. 2023 Feb 01; 192(2):205-216.
Score: 0.198
-
Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus. Virology. 2020 07; 546:38-50.
Score: 0.163
-
Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination. Mayo Clin Proc. 2015 Jul; 90(7):865-73.
Score: 0.117
-
Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons. J Gen Virol. 2017 Jun; 98(6):1434-1438.
Score: 0.034